BioAge Labs (BIOA) Invested Capital (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Invested Capital data on file, last reported at $500000.0 in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 91.67% year-over-year to $500000.0; the trailing twelve-month figure through Mar 2026 stood at $11.0 million (down 38.89% YoY), and the FY2025 full-year result was $2.0 million, down 66.67% from the prior year.
• Invested Capital fell to $500000.0 in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $6.0 million in Q4 2023 to a low of $500000.0 in Q1 2026.
• A 4-year average of $4.4 million and a median of $5.5 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital changed 0.0% in 2024 and sank 91.67% in 2026, its largest moves.
• Tracing BIOA's Invested Capital over 4 years: stood at $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then tumbled by 66.67% to $2.0 million in 2025, then tumbled by 75.0% to $500000.0 in 2026.
• Business Quant data shows BIOA's Invested Capital at $500000.0 in Q1 2026, $2.0 million in Q4 2025, and $3.5 million in Q3 2025.